To Compare the Efficacy and Safety of LAYLA in Osteoarthritis Patients

PHASE4CompletedINTERVENTIONAL

Enrollment

124

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

September 30, 2013

Conditions

Osteoarthritis of the Knee

Interventions

DRUG

LAYLA tablet

1 tablet twice a day

DRUG

JOINS tablet

1 tablet at each time, 3 times a day

Trial Locations (6)

Keimyug University Dongsan Medical Center, Daegu

Hanyang University Guri Hospital, Seoul

Korea University Anam Hospital, Seoul

Samsung Medical Center, Seoul

SMG-SNU Boramae Medical Center, Seoul

Ajou University Hospital, Suwon

All Listed Sponsors

lead

PMG Pharm Co., Ltd

INDUSTRY

NCT01768468 - To Compare the Efficacy and Safety of LAYLA in Osteoarthritis Patients | Biotech Hunter | Biotech Hunter